Arzeda, INVISTA partner to build up new technology to enable novel bio-derived processes INVISTA Technology S.l. And Arzeda Corp. Announce a collaboration for the development of brand-new systems to enable novel bio-derived processes. The agreement includes complementary technologies: INVISTA's capabilities in catalysis and biotechnology, and knowledge of the chemicals industry; and Arzeda's unique man made biology and enzyme design capabilities. Both companies are collaborating in order to additional co-develop their technology platforms, with the target to ultimately develop new bio-derived processes for a variety of products. Related StoriesUsing smart phone to detect diabetes marker in salivaAmgen's IMLYGIC receives positive opinion from CHMP for treatment of melanomaUniversity of Leicester awarded BBSRC grant to explore three key areas that influence human health The original focus of the collaboration shall be on the production of bio-derived butadiene.Hebert Family members Camp, begins April 16 and coincides with Hebert’s birthday, April 13. Related StoriesAdvances in whole mount mind imaging: an interview with Patrick Myles, President, Huron Digital PathologyUCLA Wellness adopts GenomOncology's Move Clinical Workbench to accelerate analysis for tumor DNA profiling testsDiscovery can lead to new anti-metastasis therapies for advanced-stage brain cancer patientsThe James W. Hebert Family members Camp provides peer support, respite, mentoring, and recreation for children with human brain tumors, their parents and siblings.’ SOURCE The Okizu Foundation..